Show Search Form

Search Results

human indexable	true false
published	true false
registered interest	true false
answer date	exactly: or between: and
date	exactly: or between: and
date tabled	exactly: or between: and
ddp created	exactly: or between: and
answering body
question status
answering dept id
answering dept short name
answering dept sort name
ddp modified
hansard heading
house id
identifier
legislature	pref label
parliament number
question first answered
question text
session
session number
tabling member constituency
tabling member printed
title
type
uin
version
written parliamentary question type
answer	is ministerial correction true false
creator	label
publisher	pref label
tabling member	label

Search

867044

	human indexable
	published
	registered interest
	answer date	21/03/2018
	date	19/03/2018
	date tabled	19/03/2018
	ddp created	19/03/2018 23:02:42
	answering body	Department of Health and Social Care
	question status	Tabled
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	ddp modified	19/03/2018 23:07:55 27/03/2018 12:20:02
	hansard heading	Pharmaceutical Price Regulation Scheme
	house id	1
	identifier	133162
	legislature	25259 pref label House of Commons
	parliament number	57
	question first answered	27/03/2018 11:48:24
	question text	To ask the Secretary of State for Health and Social Care, what progress his Department has made on negotiating a new Pharmaceutical Price Regulation Scheme.
	session	2017/19
	session number	1
	tabling member constituency	Stafford
	tabling member printed	Jeremy Lefroy
	title	House of Commons Tabled Parliamentary Question 2017/19 133162
	type	WrittenParliamentaryQuestion
	uin	133162
	version	1
	written parliamentary question type	Ordinary
	answer	answer is ministerial correction
	creator	4109 label Biography information for Jeremy Lefroy
	publisher	25259 pref label House of Commons
	tabling member	4109 label Biography information for Jeremy Lefroy

873628

	human indexable
	published
	registered interest
	answer date	16/04/2018
	date	28/03/2018
	date tabled	28/03/2018
	ddp created	28/03/2018 19:34:34
	answering body	Department of Health and Social Care
	question status	Tabled
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	ddp modified	28/03/2018 19:40:40 17/04/2018 14:36:01
	hansard heading	Spondyloarthritis
	house id	1
	identifier	134742
	legislature	25259 pref label House of Commons
	parliament number	57
	question first answered	17/04/2018 14:04:58
	question text	To ask the Secretary of State for Health and Social Care, what steps his Department is taking to ensure the monitoring of individual Quality Statement measures in the NICE Quality Standard on Spondyloarthritis, to be published in June 2018.
	session	2017/19
	session number	1
	tabling member constituency	Stafford
	tabling member printed	Jeremy Lefroy
	title	House of Commons Tabled Parliamentary Question 2017/19 134742
	type	WrittenParliamentaryQuestion
	uin	134742
	version	1
	written parliamentary question type	Ordinary
	answer	answer is ministerial correction
	creator	4109 label Biography information for Jeremy Lefroy
	publisher	25259 pref label House of Commons
	tabling member	4109 label Biography information for Jeremy Lefroy

873629

	human indexable
	published
	registered interest
	answer date	16/04/2018
	date	28/03/2018
	date tabled	28/03/2018
	ddp created	28/03/2018 19:34:36
	answering body	Department of Health and Social Care
	question status	Tabled
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	ddp modified	28/03/2018 19:40:44 17/04/2018 14:31:01
	hansard heading	Arthritis
	house id	1
	identifier	134743
	legislature	25259 pref label House of Commons
	parliament number	57
	question first answered	17/04/2018 13:59:58
	question text	To ask the Secretary of State for Health and Social Care, what the timetable is for the publication of the Rheumatoid and Early Inflammatory Arthritis Annual Report; and whether that report will include additional data collection for spondyloarthritis patients.
	session	2017/19
	session number	1
	tabling member constituency	Stafford
	tabling member printed	Jeremy Lefroy
	title	House of Commons Tabled Parliamentary Question 2017/19 134743
	type	WrittenParliamentaryQuestion
	uin	134743
	version	1
	written parliamentary question type	Ordinary
	answer	answer is ministerial correction
	creator	4109 label Biography information for Jeremy Lefroy
	publisher	25259 pref label House of Commons
	tabling member	4109 label Biography information for Jeremy Lefroy

882155

	human indexable
	published
	registered interest
	answer date	17/04/2018
	date	13/04/2018
	date tabled	13/04/2018
	ddp created	13/04/2018 15:45:57
	answering body	Department of Health and Social Care
	question status	Tabled
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	ddp modified	13/04/2018 15:55:28 19/04/2018 12:00:03
	hansard heading	Pharmaceutical Price Regulation Scheme
	house id	1
	identifier	135214
	legislature	25259 pref label House of Commons
	parliament number	57
	question first answered	19/04/2018 11:28:11
	question text	To ask the Secretary of State for Health and Social Care, what the timetable for negotiations on the new pharmaceutical price regulation scheme is; and if he will make a statement.
	session	2017/19
	session number	1
	tabling member constituency	Stafford
	tabling member printed	Jeremy Lefroy
	title	House of Commons Tabled Parliamentary Question 2017/19 135214
	type	WrittenParliamentaryQuestion
	uin	135214
	version	1
	written parliamentary question type	Ordinary
	answer	answer is ministerial correction
	creator	4109 label Biography information for Jeremy Lefroy
	publisher	25259 pref label House of Commons
	tabling member	4109 label Biography information for Jeremy Lefroy

964649

	human indexable
	published
	registered interest
	answer date	05/09/2018
	date	03/09/2018
	date tabled	03/09/2018
	ddp created	03/09/2018 17:40:09
	answering body	Department of Health and Social Care
	question status	Tabled
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	ddp modified	03/09/2018 18:13:39 11/09/2018 15:09:01
	hansard heading	Medical Treatments: Innovation
	house id	1
	identifier	169360
	legislature	25259 pref label House of Commons
	parliament number	57
	question first answered	11/09/2018 14:37:19
	question text	To ask the Secretary of State for Health and Social Care, what progress his Department has made on establishing an Accelerated Access Collaborative to manage the new accelerated access pathway.
	session	2017/19
	session number	1
	tabling member constituency	Stafford
	tabling member printed	Jeremy Lefroy
	title	House of Commons Tabled Parliamentary Question 2017/19 169360
	type	WrittenParliamentaryQuestion
	uin	169360
	version	1
	written parliamentary question type	Ordinary
	answer	answer is ministerial correction
	creator	4109 label Biography information for Jeremy Lefroy
	publisher	25259 pref label House of Commons
	tabling member	4109 label Biography information for Jeremy Lefroy

964650

	human indexable
	published
	registered interest
	answer date	05/09/2018
	date	03/09/2018
	date tabled	03/09/2018
	ddp created	03/09/2018 17:40:11
	answering body	Department of Health and Social Care
	question status	Tabled
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	ddp modified	03/09/2018 18:13:41 11/09/2018 15:07:03
	hansard heading	Medical Treatments: Innovation
	house id	1
	identifier	169361
	legislature	25259 pref label House of Commons
	parliament number	57
	question first answered	11/09/2018 14:35:39
	question text	To ask the Secretary of State for Health and Social Care, when the accelerated access pathway is planned to begin designating breakthrough products.
	session	2017/19
	session number	1
	tabling member constituency	Stafford
	tabling member printed	Jeremy Lefroy
	title	House of Commons Tabled Parliamentary Question 2017/19 169361
	type	WrittenParliamentaryQuestion
	uin	169361
	version	1
	written parliamentary question type	Ordinary
	answer	answer is ministerial correction
	creator	4109 label Biography information for Jeremy Lefroy
	publisher	25259 pref label House of Commons
	tabling member	4109 label Biography information for Jeremy Lefroy